Literature DB >> 12091054

Reductions in platelet contractile force correlate with duration of cardiopulmonary bypass and blood loss in patients undergoing cardiac surgery.

Philip E Greilich1, Chad F Brouse, Joseph Beckham, Michael E Jessen, Erika J Martin, Marcus E Carr.   

Abstract

Blood loss secondary to platelet dysfunction is known to be increased when the duration of cardiopulmonary bypass (CPB) is prolonged. The ability to correlate alterations in platelet function with the duration of bypass and early postoperative blood loss, however, has remained elusive. Platelet contractile force, a novel measure of platelet-mediated clot retraction, is known to be reduced following cardiac surgery and blockade of platelet adhesion receptors. The aim of this study was to determine if alterations in platelet contractile force (measured using whole blood) correlated with the duration of CPB and early postoperative blood loss. Thirty patients were entered into a study designed to measure platelet function before, during, and after CPB. Platelet aggregometry and surface expression of CD42b and CD61 were also measured (using whole blood) in a subset of subjects (n=10) to further characterize the intrinsic structural and functional defects induced by CPB. Reductions in platelet contractile force had a significant correlation with duration of CPB (r=0.564; P=0.002) and early blood loss (r=0.545; P=0.003). Although decreases in platelet contractile force and aggregation both correlated with CPB time in the smaller subset of patients tested, only platelet contractile force correlated with decreases in CD42b, CD61 and blood loss. The results of this study suggest that prolongation of CPB is related to increasing degrees of platelet dysfunction and that reductions in platelet contractile force are related to decreases in platelet adhesion receptors and early postoperative blood loss.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12091054     DOI: 10.1016/s0049-3848(02)00061-0

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  7 in total

1.  Three-factor prothrombin complex concentrates for refractory bleeding after cardiovascular surgery within an algorithmic approach to haemostasis.

Authors:  Nazish K Hashmi; Kamrouz Ghadimi; Amudan J Srinivasan; Yi-Ju Li; Robert D Raiff; Jeffrey G Gaca; Adam G Root; Yaron D Barac; Thomas L Ortel; Jerrold H Levy; Ian J Welsby
Journal:  Vox Sang       Date:  2019-04-02       Impact factor: 2.144

Review 2.  Coagulation disorders of cardiopulmonary bypass: a review.

Authors:  Domenico Paparella; Stephanie J Brister; Michael R Buchanan
Journal:  Intensive Care Med       Date:  2004-07-24       Impact factor: 17.440

3.  Contraction of Blood Clots Is Impaired in Acute Ischemic Stroke.

Authors:  Valerie Tutwiler; Alina D Peshkova; Izabella A Andrianova; Dina R Khasanova; John W Weisel; Rustem I Litvinov
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-12-01       Impact factor: 8.311

4.  Epac1-deficient mice have bleeding phenotype and thrombocytes with decreased GPIbβ expression.

Authors:  Gyrid Nygaard; Lars Herfindal; Kathrine S Asrud; Ronja Bjørnstad; Reidun K Kopperud; Eystein Oveland; Frode S Berven; Lene Myhren; Erling A Hoivik; Turid Helen Felli Lunde; Marit Bakke; Stein O Døskeland; Frode Selheim
Journal:  Sci Rep       Date:  2017-08-18       Impact factor: 4.379

5.  Reduced Contraction of Blood Clots in Venous Thromboembolism Is a Potential Thrombogenic and Embologenic Mechanism.

Authors:  Alina D Peshkova; Dmitry V Malyasyov; Roman A Bredikhin; Giang Le Minh; Izabella A Andrianova; Valerie Tutwiler; Chandrasekaran Nagaswami; John W Weisel; Rustem I Litvinov
Journal:  TH Open       Date:  2018-03-28

6.  Relationship of Platelet Counts and Inflammatory Markers to 30-Day Mortality Risk in Patients with Acute Type A Aortic Dissection.

Authors:  Yiping Chen; Yanjuan Lin; Haoruo Zhang; Yanchun Peng; Sailan Li; Xizhen Huang
Journal:  Biomed Res Int       Date:  2020-04-21       Impact factor: 3.411

7.  Topical recombinant thrombin at a concentration of 1000 IU/mL reliably shortens in vivo TTH and delivers durable hemostasis in the presence of heparin anticoagulation and clopidogrel platelet inhibition in a rabbit model of vascular bleeding.

Authors:  Steven D Hughes; Paul D Bishop; Richard Garcia; Tracy Zhang; W Allan Alexander
Journal:  Ann Surg Innov Res       Date:  2009-11-19
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.